ALK inhibitors

/Tag:ALK inhibitors

Using PCR to personalise lung cancer treatment

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, and the ALK inhibitors have potential in targeted treatment of the disease. However, they are only effective in patients who have rearrangements in the anaplastic lymphoma receptor [...]

The xxcloud is our exciting new software release, enabling users to programme and analyse results remotely, from a PC or laptop.


Cost Savings CalculatorWhere to buyContact us